Eligibility for anti-fibrotic therapy of patients in British Thoracic Society (BTS) UK IPF Registry varies according to the reference values used to calculate FVC

P. Molyneaux (London, United Kingdom), M. Loughenbury (London, United Kingdom), S. Welham (London, United Kingdom), J. Hutchinson (Notingham, United Kingdom), H. Adamali (Bristol, United Kingdom), A. Fahim (Wolverhampton, United Kingdom), S. Agnew (Liverpool, United Kingdom), W. Funston (Gateshead, United Kingdom), S. Haney (Ashington, United Kingdom), L. Ho (Oxford, United Kingdom), J. Richardson (London, United Kingdom), H. Almond (Bury St Edmunds, United Kingdom), S. Jones (Bury St Edmunds, United Kingdom), L. Nicol (Edinburgh, United Kingdom), K. Spinks (Lymington, United Kingdom), A. Wilson (Norwich, United Kingdom), L. Spencer (Liverpool, United Kingdom)

Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Session: What is hot in idiopathic pulmonary fibrosis?
Session type: E-poster session
Number: 1798
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Molyneaux (London, United Kingdom), M. Loughenbury (London, United Kingdom), S. Welham (London, United Kingdom), J. Hutchinson (Notingham, United Kingdom), H. Adamali (Bristol, United Kingdom), A. Fahim (Wolverhampton, United Kingdom), S. Agnew (Liverpool, United Kingdom), W. Funston (Gateshead, United Kingdom), S. Haney (Ashington, United Kingdom), L. Ho (Oxford, United Kingdom), J. Richardson (London, United Kingdom), H. Almond (Bury St Edmunds, United Kingdom), S. Jones (Bury St Edmunds, United Kingdom), L. Nicol (Edinburgh, United Kingdom), K. Spinks (Lymington, United Kingdom), A. Wilson (Norwich, United Kingdom), L. Spencer (Liverpool, United Kingdom). Eligibility for anti-fibrotic therapy of patients in British Thoracic Society (BTS) UK IPF Registry varies according to the reference values used to calculate FVC. 1798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: